Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Ellen G. McMahon"'
Publikováno v:
Mini-Reviews in Medicinal Chemistry. 5:709-718
Mineralocorticoid receptor (MR) antagonism has proven to effectively attenuate the pathophysiological effects of aldosterone in clinical and experimental settings of hypertension and heart failure. MR activates transcription of target genes upon aldo
Autor:
Anastassia Todor, Ellen G. McMahon, Sidney Goldstein, Hideaki Morita, Victor G. Sharov, George Suzuki, Elaine J. Tanhehco, Hani N. Sabbah, Amy E. Rudolph, Takayuki Mishima
Publikováno v:
Circulation. 106:2967-2972
Background— In heart failure (HF), aldosterone has been implicated in the formation of reactive interstitial fibrosis, a maladaptation that contributes to left ventricular (LV) remodeling. Eplerenone is a novel selective aldosterone blocker. The pr
Autor:
Pochang Yang, Rachel Scherrer, John A. Delyani, Ricardo Rocha, Ellen G. McMahon, Cynthia L. Martin-Berger
Publikováno v:
Endocrinology. 143:4828-4836
We studied the role of aldosterone (aldo) in myocardial injury in a model of angiotensin (Ang) II-hypertension. Wistar rats were given 1% NaCl (salt) to drink and randomized into one of the following groups (n = 10; treatment, 21 d): 1) vehicle contr
Autor:
Ellen G. McMahon
Publikováno v:
Current Opinion in Pharmacology. 1:190-196
Activation of the renin–angiotensin–aldosterone system is associated with unsatisfactory outcomes in patients with hypertension and congestive heart failure, in that activation of this system is correlated strongly with both the incidence and ext
Autor:
Stuart A. Ross, Shaping Sun, Kay Broschat, Xiaoli Chen, Eric Arthur Gulve, Ellen G. Mcmahon, Heidi Rath Hope
Publikováno v:
Biochemical and Biophysical Research Communications. 273:1033-1041
Insulin resistance can be induced in vivo by intravenous infusion of glucosamine or in cells by incubation with glucosamine. However, a publication (Hresko, R. C., et al. (1998) J. Biol. Chem. 273, 20658-20668) suggests a trivial explanation of gluco
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 275:E272-E277
Lithium has been shown to increase glucose uptake in skeletal muscle and adipose tissues. The therapeutic effect of lithium on bipolar disease is thought to be mediated by its inhibitory effect on myo-inositol-1-monophosphatase (IMPase). We tested th
Autor:
Maria A. Palomo, Gillian M. Olins, Ellen G. Mcmahon, Timothy S. Chamberlain, Susan T. Chen, Robert E. Manning, Edward H. Blaine, Horng-Chih Huang, Valerie M. Corpus
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 4:2591-2596
A series of potent, selective, conformationally restricted angiotensin II (AII) receptor antagonists has been discovered. Two classes of conformationally restricted analogues were prepared: triazolone-based and imidazole-based biphenyl derivatives. T
Autor:
David B. Reitz, Ellen G. McMahon, Maria A. Palomo, Mark A. Penick, Gillian M. Olins, Brian Kai-Ming Cheng, Dean E. McGraw, Valerie M. Corpus, Emily J. Reinhard
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 4:99-104
Substituting nitrogen for carbon in the pyridinylphenylmethyl analogs of SC-50560 proved to be detrimental, however, the two phenylpyridinylmethyl analogs of SC-50560 retained their potencies. Of these two analogs, SC-52458 was found to have superior
Autor:
Maria A. Palomo, Ellen G. Mcmahon, Melanie A. Brown, Jeffery S. Carter, Stephen R. Bertenshaw
Publikováno v:
American Journal of Hypertension. 6:667-673
We reported previously that the endothelin converting enzyme (ECE) inhibitor phosphoramidon lowers mean arterial pressure (MAP) when infused in conscious, spontaneously hypertensive rats (SHRs). In this study we determined the dose-response relations
Autor:
Maria A. Palomo, Danny J. Garland, Konrad F. Koehler, David B. Reitz, Monica B. Norton, Emily J. Reinhard, Gillian M. Olins, Susan T. Chen, Robert E. Manning, J. T. Collins, Ellen G. McMahon
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 3:1055-1060
The surmountable (competitive) N 1 -(2-methylphenyl)-2H-imidazol-2-one angiotensin II receptor antagonist SC-54628 is converted to an insurmountable (noncompetitive) antagonist SC-54629 by the addition of a methyl group at the 6-position of the pheny